Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated Oligonucleosomes-Reference-Cited by-同舟云学术

Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated Oligonucleosomes

Published:2022-07 Issue:5 Volume:27 Page:306-313
ISSN:2472-5552
Container-title:SLAS Discovery
language:en
Short-container-title:SLAS Discovery

Author:

Lercher Lukas,Simon Nina,Bergmann Andreas^ORCID,Tauchert Marcel^ORCID,Bochmann David^ORCID,Bashir Tarig,Neuefeind Torsten,Riley Daniel,Danna Ben,Krawczuk Paul^ORCID,Pande Vineet^ORCID,Patrick Aaron,Steele Ruth^ORCID,Wang Weixue^ORCID,Rupnow Brent,Tummino Peter,Sharma Sujata,Finley Michael^ORCID

Publisher

Elsevier BV

Subject

Molecular Medicine,Biochemistry,Analytical Chemistry,Biotechnology

Reference43 articles.

1. N-Myc induces EZH2-mediated transcriptional program driving neuroendocrine prostate cancer;Dardenne;Cancer Cell,2016

2. Mouse Polycomb Proteins Bind Differentially to Methylated Histone H3 and RNA and Are Enriched in Facultative Heterochromatin;Bernstein;Mol. Cell. Biol.,2006

3. Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer;Clermont;Clin. Epigenetics,2016

4. Polycomb-mediated silencing in neuroendocrine prostate cancer;Clermont;Clin. Epigenetics,2015

5. Interplay between the cancer genome and epigenome;Shen;Cell,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics analysis reveals that CBX2 promotes enzalutamide resistance in prostate cancer;European Journal of Medical Research;2024-08-22

2. Chemical inhibitors targeting histone methylation readers;Pharmacology & Therapeutics;2024-04

3. Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma;Stem Cells International;2023-04-30

4. Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library;SLAS Discovery;2022-12